Crestline Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-14,120
| Closed | -$494K | – | 245 |
|
|
2018
Q2 | $494K | Buy |
14,120
+4,059
| +40% | +$142K | 0.05% | 224 |
|
|
2018
Q1 | $468K | Buy |
+10,061
| New | +$468K | 0.06% | 196 |
|
|
2017
Q3 | – | Sell |
-21,990
| Closed | -$1.25M | – | 181 |
|
|
2017
Q2 | $1.25M | Buy |
21,990
+7,770
| +55% | +$443K | 0.17% | 68 |
|
|
2017
Q1 | $764K | Buy |
+14,220
| New | +$764K | 0.14% | 68 |
|